Bo-Ragnar Tolf
Corporate Officer/Principal at Karolinska Institutet
Bo-Ragnar Tolf active positions
Companies | Position | Start | End |
---|---|---|---|
Karolinska Institutet | Corporate Officer/Principal | - | - |
Career history of Bo-Ragnar Tolf
Former positions of Bo-Ragnar Tolf
Companies | Position | Start | End |
---|---|---|---|
Kabi Pharmacia | Corporate Officer/Principal | 1990-12-31 | 1990-12-31 |
Pharmacia Ophthalmics AB | Chief Tech/Sci/R&D Officer | 1984-12-31 | 1988-12-31 |
SENSIDOSE AB | Director/Board Member | 2010-12-31 | - |
KDev Exploratory AB
KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Director/Board Member | 2009-12-31 | - |
INHALATION SCIENCES SWEDEN AB | Director/Board Member | - | - |
BioChromix Pharma AB
BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services BioChromix Pharma AB was founded as a subsidiary to BioChromix AB. The Company is a pharmaceutical company active in research and development of novel treatments for neurodegenerative disorders based on its proprietary technology for therapeutics. Current research and development is focused on the indication area of Alzheimer's disease but the prion diseases, Parkinson's disease and other neurodegenerative disorders might also be included in the future. BioChromix Pharma is performing pre-clinical development but is looking to reach the clinical phase within the coming years. Alzheimer's disease is the most common neurodegenerative disease, affecting around 25 million people and the costs associated with AD are tremendous. At the moment, there are no efficient treatments for AD but there are clinical trials are ongoing and some are focused at reducing the levels of the neurotoxic Aß peptide. The portfolio of the company includes a number of newly discovered lead compounds that are under investigation. | Director/Board Member | 2011-01-12 | - |
Astra Arcus AB | Corporate Officer/Principal | - | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 1990-12-31 | - |
░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Bo-Ragnar Tolf
University of Uppsala | Doctorate Degree |
Statistics
International
Sweden | 11 |
United States | 2 |
Denmark | 2 |
Operational
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
President | 1 |
Sectoral
Commercial Services | 4 |
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ACADIA PHARMACEUTICALS INC. | Health Technology |
INHALATION SCIENCES SWEDEN AB | Health Technology |
SENSIDOSE AB | Electronic Technology |
Private companies | 7 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Acadia Pharmaceuticals AB | |
KDev Exploratory AB
KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Commercial Services |
Astra Arcus AB | |
Pharmacia Ophthalmics AB | |
Kabi Pharmacia | |
BioChromix Pharma AB
BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services BioChromix Pharma AB was founded as a subsidiary to BioChromix AB. The Company is a pharmaceutical company active in research and development of novel treatments for neurodegenerative disorders based on its proprietary technology for therapeutics. Current research and development is focused on the indication area of Alzheimer's disease but the prion diseases, Parkinson's disease and other neurodegenerative disorders might also be included in the future. BioChromix Pharma is performing pre-clinical development but is looking to reach the clinical phase within the coming years. Alzheimer's disease is the most common neurodegenerative disease, affecting around 25 million people and the costs associated with AD are tremendous. At the moment, there are no efficient treatments for AD but there are clinical trials are ongoing and some are focused at reducing the levels of the neurotoxic Aß peptide. The portfolio of the company includes a number of newly discovered lead compounds that are under investigation. | Commercial Services |
- Stock Market
- Insiders
- Bo-Ragnar Tolf
- Experience